المؤلفون: Shi, J, Gosselin, NH, Chen, C, Wang, R, San Martin, J

المصدر: In Value in Health May 2018 21 Supplement 1:S246-S246

المؤلفون: Edwards, JE, LaCerte, C, Peyret, T, Gosselin, NH, Marier, JF, Hofmann, AF, Shapiro, D

المصدر: CTS: Clinical & Translational Science; Dec2016, Vol. 9 Issue 6, p328-336, 9p

مصطلحات موضوعية: BILE acids, FARNESOID X receptor, CIRRHOSIS of the liver, LIVER injuries, PHARMACOKINETICS

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Marier J, Mouksassi M, Gosselin NH, Beliveau M, Cyran J, Wallens J

المصدر: Journal of Clinical Pharmacology; Jan2010, Vol. 50 Issue 1, p36-49, 14p

المؤلفون: Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, UK. Electronic address: k.ray@imperial.ac.uk., Gunn LH; Department of Public Health Sciences and School of Data Science, University of North Carolina at Charlotte, Charlotte, NC, USA; Department of Primary Care and Public Health, Imperial College, London, UK., Conde LG; Novartis Pharma AG, Basel, Switzerland., Raal FJ; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Wright RS; Division of Preventive Cardiology and the Department of Cardiology, Mayo Clinic, Rochester, MN, USA., Gosselin NH; Certara, Princeton, NJ, USA., Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Canada., Koenig W; Deutsches Herzzentrum München, Technische Universität München, and German Center for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and the Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany., Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA., Landmesser U; Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum Charité, Charité-Universitätsmedizin Berlin, Friede Springer Cardiovascular Prevention Center@Charité, DZHK, Partner Site Berlin, Germany.

مؤلفون مشاركون: ORION investigators

المصدر: Atherosclerosis [Atherosclerosis] 2024 Apr; Vol. 391, pp. 117472. Date of Electronic Publication: 2024 Feb 15.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Anticholesteremic Agents* , Cardiovascular Diseases*/genetics , Cardiovascular Diseases*/prevention & control , Cardiovascular Diseases*/drug therapy, Humans ; Cholesterol, LDL ; RNA, Small Interfering ; Proprotein Convertase 9

المؤلفون: Gosselin NH; Certara, Cambridge, Massachusetts, USA., Schuck VJA; Certara, Cambridge, Massachusetts, USA., Barriere O; Certara, Cambridge, Massachusetts, USA., Kulmatycki K; Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA., Margolskee A; Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA., Smith P; Certara, Cambridge, Massachusetts, USA., He Y; Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Feb; Vol. 113 (2), pp. 328-338. Date of Electronic Publication: 2022 Nov 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Hypercholesterolemia*/drug therapy , Anticholesteremic Agents*, Humans ; Proprotein Convertase 9/genetics ; Cholesterol, LDL ; RNA, Small Interfering/genetics